Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy

Rituximab (RTX), an anti-CD20 monoclonal antibody, has shown to be an effective induction treatment for small-vessel vasculitides associated with antineutrophil cytoplasm antibodies (AAV) in both newly diagnosed and relapsing patients. However, the role of RTX in the management of the most severe ca...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Dario Roccatello, Savino Sciascia, Stefano Murgia, Giacomo Quattrocchio, Michela Ferro, Emanuele De Simone, Carla Naretto, Antonella Barreca, Andrea Sammartino, Daniela Rossi, Roberta Fenoglio
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2022-03-01
Σειρά:	Frontiers in Immunology
Θέματα:	ANCA-associated vasculitis rituximab glomerulonephritis vasculitis polyangiitis and granulomatosis polyangiitis
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.777134/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!